Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $3.1 million.

  • Selectis Health's Shares Outstanding (Diluted Average) changed 0.0% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.1 million for FY2024, which is 40.83% up from last year.
  • As of Q3 2025, Selectis Health's Shares Outstanding (Diluted Average) stood at $3.1 million, which was down 0.0% from $3.1 million recorded in Q2 2025.
  • Selectis Health's Shares Outstanding (Diluted Average)'s 5-year high stood at $3.1 million during Q1 2024, with a 5-year trough of $2.7 million in Q2 2021.
  • In the last 5 years, Selectis Health's Shares Outstanding (Diluted Average) had a median value of $3.1 million in 2022 and averaged $3.0 million.
  • In the last 5 years, Selectis Health's Shares Outstanding (Diluted Average) tumbled by 9033.03% in 2021 and then surged by 1358.94% in 2022.
  • Over the past 5 years, Selectis Health's Shares Outstanding (Diluted Average) (Quarter) stood at $2.8 million in 2021, then grew by 10.33% to $3.1 million in 2022, then grew by 0.02% to $3.1 million in 2023, then increased by 0.41% to $3.1 million in 2024, then changed by 0.0% to $3.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $3.1 million for Q3 2025, versus $3.1 million for Q2 2025 and $3.1 million for Q1 2025.